These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 85500

  • 21. Chemical modification of fortimicins: preparation of 4-N-substituted fortimicin B.
    Sato M, Mori Y.
    J Antibiot (Tokyo); 1979 Apr; 32(4):371-8. PubMed ID: 468724
    [Abstract] [Full Text] [Related]

  • 22. Mutational biosynthesis of butirosin analogs. III. 6'-N-methylbutirosins and 3', 4'-dideoxy-6'-c-methylbutirosins, new semisynthetic aminoglycosides.
    Takeda K, Kinumaki A, Okuno S, Matsushita T, Ito Y.
    J Antibiot (Tokyo); 1978 Oct; 31(10):1039-45. PubMed ID: 81824
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sorbistin, a new aminoglycoside antibiotic complex of bacterial origin. I. Production, isolation and properties.
    Tsukiura H, Hanada M, Saito K, Fujisawa K, Miyaki T.
    J Antibiot (Tokyo); 1976 Nov; 29(11):1137-46. PubMed ID: 993100
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antibiotics derived from a mutant of Bacillus circulans.
    Taylor HD, Schmitz H.
    J Antibiot (Tokyo); 1976 May; 29(5):532-5. PubMed ID: 60328
    [Abstract] [Full Text] [Related]

  • 28. Butirosin compared with gentamicin in vitro and in vivo.
    Heifetz CL, Chodubski JA, Pearson IA, Silverman CA, Fisher MW.
    Antimicrob Agents Chemother; 1974 Aug; 6(2):124-35. PubMed ID: 15828182
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Assessment of 6'- and 6'''-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance.
    Shaul P, Green KD, Rutenberg R, Kramer M, Berkov-Zrihen Y, Breiner-Goldstein E, Garneau-Tsodikova S, Fridman M.
    Org Biomol Chem; 2011 Jun 07; 9(11):4057-63. PubMed ID: 21365081
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. 2-Deoxystreptamine: central scaffold of aminoglycoside antibiotics.
    Busscher GF, Rutjes FP, van Delft FL.
    Chem Rev; 2005 Mar 07; 105(3):775-91. PubMed ID: 15755076
    [No Abstract] [Full Text] [Related]

  • 36. Chemical modification of fortimicins. III. preparation of N-substituted fortimicin A derivatives.
    Mochida K, Sato M, Yoshiie S, Mori Y, Shirahata K, Kitaura K.
    J Antibiot (Tokyo); 1981 May 07; 34(5):522-9. PubMed ID: 7275834
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Design and synthesis of pyrankacin: a pyranmycin class of broad-spectrum aminoglycoside antibiotic.
    Rai R, Chen HN, Czyryca PG, Li J, Chang CW.
    Org Lett; 2006 Mar 02; 8(5):887-9. PubMed ID: 16494466
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.